// App-Quantinova.ai

e16200 : Treatments and ongoing monitoring for patients with neuroendocrine tumors, monitored by medical oncologists: Scan comparative data between advanced economies (AE) and emerging and developing economies (EDE).

Researchers

Presenter

  • Christine Rodien-Louw

Principal Investigators

  • Mark McDonnell

  • Teodora Kolarova

  • Catherine Bouvier

  • Marianne E Pavel

  • Rodney J. Hicks

  • Jie Chen

  • Simron Singh

  • Dirk Van Genechten

  • Dermot O'Toole

  • Elyse Gellerman

  • Sugandha Dureja

  • Simone Leyden

  • James R. Howe

Medical Centers

  • APTED Association de Patients Porteurs de Tumeurs Endocrines Diverses, Lyon, France

  • NET Patient Network, Dublin, Ireland

  • International Neuroendocrine Cancer Alliance, Boston, MA

  • Neuroendocrine Cancer UK, Leamington Spa, United Kingdom

  • Charite-Universitatsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany

  • Peter MacCallum Cancer Centre, East Melbourne, Australia

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Canada.

  • VZW NET & Men Kanker Belgium

  • Kortrijk, Belgium

  • Saint James's Hospital, Dublin, Ireland

  • NET Research Foundation (NETRF), Boston, MA

  • Action Cancer Hospital, New Delhi, Delhi, India

  • NeuroEndocrine Cancer Australia

  • N/A, Victoria, Australia

  • University of Iowa, Carver College of Medicine, Iowa City, IA

Locations

  • France

  • Ireland

  • United States

  • United Kingdom

  • Germany

  • Australia

  • China

  • Canada

  • Belgium

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroendocrine tumors

Biomarkers

  • N/A

Drug/Treatment

  • Somatostatin

  • Ga-68

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved